SCHEMBL4449928

SCHEMBL4449928

CCCCc1ccc(/C=C/c2ccc3ccc4ccc(/C=C/c5ccc(CCCC)cc5)c5ccc2c3c45)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
SPHK1 Q9NYA1 2/20 0.40
MCHR1 Q99705 1/20 0.39
CA2 P00918 2/20 0.37
CA1 P00915 1/20 0.37
SPHK2 Q9NRA0 1/20 0.36
CHAT P28329 1/20 0.36
TRPM2 O94759 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3478454 1.00 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3478453 1.00 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4449932 1.00 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4444145 0.91 MCHR1 (0.38) MCHR1CA2CHATALDH1A1HPGD
SCHEMBL4441478 0.84 ALOX5 (0.44) CYP2C9MCHR1CHATSMN1; SMN2KDM4E
SCHEMBL4451024 0.82 SPHK1 (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4451022 0.82 SPHK1 (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL10058055 0.78 SPHK2 (0.38) CYP3A4CYP2D6CYP2C9SPHK1SPHK2
SCHEMBL3474496 0.75 NFE2L2 (0.47) CA1SMN1; SMN2KDM4ETP53PTGS1
SCHEMBL3474498 0.75 NFE2L2 (0.47) CA1SMN1; SMN2KDM4ETP53PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090179196-A1 Pyrene-Based Organic Compound, Transistor Material and Light-Emitting Transistor Device KYUSHU UNIVERSITY (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090179196-A1 Pyrene-Based Organic Compound, Transistor Material and Light-Emitting Transistor Device PPOX, JUP, TARDBP GRIN2D 2081/4885GRIN3B 2771/4885GRIN1 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.